1. Home
  2. VRAR vs ABP Comparison

VRAR vs ABP Comparison

Compare VRAR & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$1.02

Market Cap

17.2M

Sector

Technology

ML Signal

HOLD

ABP

Abpro Holdings Inc

HOLD

Current Price

$4.85

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
ABP
Founded
2016
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
12.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VRAR
ABP
Price
$1.02
$4.85
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$2.62
N/A
AVG Volume (30 Days)
130.5K
13.9K
Earning Date
02-12-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.60
50.00
52 Week Low
$0.77
$3.78
52 Week High
$3.07
$49.50

Technical Indicators

Market Signals
Indicator
VRAR
ABP
Relative Strength Index (RSI) 52.05 49.86
Support Level $0.77 $3.98
Resistance Level $0.88 $4.30
Average True Range (ATR) 0.09 0.37
MACD 0.02 -0.11
Stochastic Oscillator 75.74 57.53

Price Performance

Historical Comparison
VRAR
ABP

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About ABP Abpro Holdings Inc

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: